Clinical Trials Browser

Not yet recruiting × Interventional × talquetamab × Clear all

NCT07474961 2026-03-16

BLOOD-dose

Phase 4 Not yet recruiting

LymphoidPlasma cell

Waldenstrom Macroglobulinemia, Multiple Myeloma

NCT07107529 2025-08-12

Study for Frail Patients With Newly Diagnosed Multiple Myeloma Treated With Daratumumab With Teclistamab or Talquetamab.

Phase 2 Not yet recruiting

Multiple Myeloma

NCT07032714 2025-06-26

MAGENTA

Phase 1 Not yet recruiting

Multiple Myeloma